Outcomes of Patients With NSTEMI and Significant CAD
Outcomes of Patients With NSTEMI and Significant CAD
Patients who present with NSTEMI and are found to have CAD on coronary angiography yet do not get revascularized constitute a high-risk subset with a high comorbidity burden. The presence of CKD is associated with an even higher prevalence of comorbidities, a further increase in mortality, and major bleeding risk yet a lower use of evidence-based drug therapy.
Conclusion
Patients who present with NSTEMI and are found to have CAD on coronary angiography yet do not get revascularized constitute a high-risk subset with a high comorbidity burden. The presence of CKD is associated with an even higher prevalence of comorbidities, a further increase in mortality, and major bleeding risk yet a lower use of evidence-based drug therapy.
